Published in Nephrol Dial Transplant on December 02, 2005
Acalculous cholecystitis with multiple organ failure and disseminated intravascular coagulation in a patient with adult onset Still's disease. Ann Gastroenterol (2014) 0.79
Eosinophilic Granulomatosis With Polyangiitis With Thrombotic Microangiopathy: Is Simultaneous Systemic Lupus Erythematosus Associated With Clinical Manifestations?: A Case Report and Review of the Literature. Medicine (Baltimore) (2015) 0.75
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature (2010) 12.27
Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med (2009) 10.60
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum (2012) 6.85
Rheumatoid arthritis association at 6q23. Nat Genet (2007) 6.71
Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study. Arthritis Rheum (2013) 4.02
Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol (2008) 2.65
Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet (2010) 2.56
Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J (2008) 2.35
The unrecognized prevalence of chronic kidney disease in diabetes. Nephrol Dial Transplant (2005) 2.24
Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trial. Transplantation (2013) 2.06
Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum (2007) 1.98
Numerical scoring for the BILAG-2004 index. Rheumatology (Oxford) (2010) 1.83
Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant (2012) 1.83
Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford) (2011) 1.79
British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum (2007) 1.74
Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) study. J Rheumatol (2009) 1.67
A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis (2002) 1.65
Body mass index has no effect on rate of progression of chronic kidney disease in non-diabetic subjects. Nephrol Dial Transplant (2012) 1.59
Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activity. Arthritis Rheum (2006) 1.56
Sudden cardiac death in hemodialysis patients: an in-depth review. Am J Kidney Dis (2011) 1.56
Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation (2004) 1.53
Factors influencing response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis. J Rheumatol (2005) 1.52
The BILAG-2004 index is sensitive to change for assessment of SLE disease activity. Rheumatology (Oxford) (2009) 1.52
Prediction and assessment of responses to renal artery revascularization with dynamic contrast-enhanced magnetic resonance imaging: a pilot study. Am J Physiol Renal Physiol (2013) 1.46
Use of a first-line urine protein-to-creatinine ratio strip test on random urines to rule out proteinuria in patients with chronic kidney disease. Nephrol Dial Transplant (2008) 1.45
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis (2014) 1.45
The clinical significance of hyperkalaemia-associated repolarization abnormalities in end-stage renal disease. Nephrol Dial Transplant (2012) 1.42
Identification of multiple, oxygen-stable HIF1 alpha isoforms, and augmented expression of adrenomedullin in rheumatoid arthritis. Clin Exp Rheumatol (2013) 1.40
Dialysis-dependent changes in ventricular repolarization. Pacing Clin Electrophysiol (2012) 1.39
Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis Rheum (2008) 1.28
The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients. Rheumatology (Oxford) (2011) 1.25
Serum phosphate and mortality in patients with chronic kidney disease. Clin J Am Soc Nephrol (2010) 1.20
Factors associated with kidney disease progression and mortality in a referred CKD population. Am J Kidney Dis (2010) 1.18
Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis. Clin J Am Soc Nephrol (2008) 1.18
Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. Ann Rheum Dis (2011) 1.17
Measurement of single kidney function using dynamic contrast-enhanced MRI: comparison of two models in human subjects. J Magn Reson Imaging (2006) 1.17
Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus. J Rheumatol (2006) 1.16
Chronic fatigue syndrome and arthralgia following parvovirus B19 infection. J Rheumatol (2002) 1.16
Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritis. Arthritis Rheum (2005) 1.16
Numerical scoring for the Classic BILAG index. Rheumatology (Oxford) (2009) 1.13
Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease. J Nephrol (2011) 1.12
Protein and albumin-to-creatinine ratios in random urines accurately predict 24 h protein and albumin loss in patients with kidney disease. Ann Clin Biochem (2009) 1.09
HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis. Ann Rheum Dis (2007) 1.08
Modifiable risk factors for RA: prevention, better than cure? Rheumatology (Oxford) (2011) 1.08
Subclinical atherosclerosis in systemic lupus erythematosus. J Rheumatol (2004) 1.07
Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Curr Opin Lipidol (2008) 1.06
The prevalence and incidence of biopsy-proven lupus nephritis in the UK: Evidence of an ethnic gradient. Arthritis Rheum (2006) 1.05
The use of eGFR and ACR to predict decline in renal function in people with diabetes. Nephrol Dial Transplant (2010) 1.04
The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis. Arthritis Rheum (2008) 1.04
Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus. Ann Rheum Dis (2013) 1.03
Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritis. Ann Rheum Dis (2010) 1.03
Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Ann Rheum Dis (2012) 1.02
The effects of statins on the progression of atherosclerotic renovascular disease. Nephron Clin Pract (2007) 1.02
25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology (Oxford) (2011) 1.02
Serious adverse incidents with the usage of low molecular weight heparins in patients with chronic kidney disease. Am J Kidney Dis (2004) 1.00
The cost of implementing UK guidelines for the management of chronic kidney disease. Nephrol Dial Transplant (2007) 0.99
Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular disease. Nephrol Dial Transplant (2011) 0.99
BOLD imaging: a potential predictive biomarker of renal functional outcome following revascularization in atheromatous renovascular disease. Nephrol Dial Transplant (2011) 0.97
The systemic lupus international collaborating clinics (SLICC) damage index: a systematic literature review. Semin Arthritis Rheum (2013) 0.97
Prolonged remission in systemic lupus erythematosus. J Rheumatol (2005) 0.96
Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris. Ann Rheum Dis (2011) 0.96
Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. J Am Soc Nephrol (2002) 0.95
Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index. Arthritis Rheum (2008) 0.94
Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response. Arthritis Rheum (2008) 0.94
Serum phosphate and left ventricular hypertrophy in young adults: the coronary artery risk development in young adults study. Kidney Blood Press Res (2009) 0.93
Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease. Nat Clin Pract Cardiovasc Med (2005) 0.93
Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging. Clin J Am Soc Nephrol (2010) 0.93
Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001. Circulation (2006) 0.92
Using lifestyle factors to identify individuals at higher risk of inflammatory polyarthritis (results from the European Prospective Investigation of Cancer-Norfolk and the Norfolk Arthritis Register--the EPIC-2-NOAR Study). Ann Rheum Dis (2013) 0.92
Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort. Ann Rheum Dis (2012) 0.91
Treat-to-target in systemic lupus erythematosus: where are we today? Clin Exp Rheumatol (2012) 0.91
Variants in RUNX3 contribute to susceptibility to psoriatic arthritis, exhibiting further common ground with ankylosing spondylitis. Arthritis Rheum (2013) 0.91
Epidemiology and natural history of atherosclerotic renovascular disease. Prog Cardiovasc Dis (2009) 0.90
Apposite insulin-like growth factor (IGF) receptor glycosylation is critical to the maintenance of vascular smooth muscle phenotype in the presence of factors promoting osteogenic differentiation and mineralization. J Biol Chem (2011) 0.90
Clinical trials in lupus: what have we learned so far? Rheumatology (Oxford) (2010) 0.89
The metabolic syndrome in systemic lupus erythematosus. Rheum Dis Clin North Am (2010) 0.89
Effects of renal volume and single-kidney glomerular filtration rate on renal functional outcome in atherosclerotic renal artery stenosis. Nephrol Dial Transplant (2009) 0.88
Anaemia in patients with diabetes: unrecognised, undetected and untreated? Curr Med Res Opin (2003) 0.87
Factors associated with vascular stiffness: cross-sectional analysis from the Chronic Renal Insufficiency Standards Implementation Study. Nephron Clin Pract (2009) 0.86
Left ventricular morphology and function in patients with atherosclerotic renovascular disease. J Am Soc Nephrol (2005) 0.86
Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study. Ann Rheum Dis (2012) 0.86
The clinical significance of early proteinuria after renal transplantation. Transplantation (2010) 0.85
Anuric acute renal failure and pulmonary oedema: a case for urgent action. Int J Cardiol (2007) 0.85
The UK model for system redesign and chronic kidney disease services. Semin Nephrol (2009) 0.85
Dilemmas in the management of renal artery stenosis. Br Med Bull (2005) 0.84
Activation of transforming growth factor-beta1 and early atherosclerosis in systemic lupus erythematosus. Arthritis Res Ther (2006) 0.84